Compare DRMA & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRMA | AMBO |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 6.5M |
| IPO Year | 2021 | 2010 |
| Metric | DRMA | AMBO |
|---|---|---|
| Price | $1.13 | $2.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 73.7K | 2.8K |
| Earning Date | 05-14-2026 | 08-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 337.04 |
| EPS | N/A | ★ 0.00 |
| Revenue | N/A | ★ $9,469,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $650.00 | N/A |
| P/E Ratio | ★ N/A | $426.53 |
| Revenue Growth | N/A | ★ 0.82 |
| 52 Week Low | $0.95 | $1.47 |
| 52 Week High | $6.22 | $6.75 |
| Indicator | DRMA | AMBO |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 48.11 |
| Support Level | $0.95 | $1.97 |
| Resistance Level | $1.40 | $2.17 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 12.11 | 33.33 |
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.